Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 46. Stephens K, Barker P, Bergeron E, Miller J L, Hagemann T M, Lewis T V, Neely S, Johnson P N. Comparison of Clinical Outcomes and Medication Use of Obese Versus Nonobese Children Admitted to the Pediatric Intensive Care Unit. Hospital pharmacy. 2021; 56 : 287-295
47. Johnson P N. Treprostinil (Remodulin(R)). 2021
48. Harkin M, Miller J L, Lim S Y, Neely S, Walsh C, Johnson P N. "Reply: Conversion From Continuous Infusion Fentanyl to Hydromorphone in the Pediatric Intensive Care Unit". The Annals of pharmacotherapy. 2021
49. Miller J L, Stephens K, Johnson P N, Medina M. Teaching residents how to deliver active learning during didactic lectures. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2021; 78 : 944-948
50. Lim S Y, Miller J L, Henry E, Heltsley R, Woo S, Johnson P N. Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill children. Pharmacotherapy. 2021; 41 : 359-369
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 21. Pediatric Pharmacy Advocacy Group. Best Student Investigator Award (Served as student mentor). Date: 2015.
22. University of Oklahoma College of Medicine, Department of Pediatrics. Best Trainee Research Award (Served as resident mentor). Date: 2015.
23. Pediatric Pharmacy Advocacy Group. Special Recognition Award. Date: 2015.
24. ACCP Pediatric Practice and Research Network. Travel Award (Served as student mentor). Date: 2014.
25. Pediatric Pharmacy Advocacy Group. Original Research Award. Date: 2014.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results